Magnetic Resonance Imaging Guided Prostate Biopsy in Patients with ≥ One Negative Systematic Transrectal Ultrasound-Guided Biopsy: A Systemic Review and Meta-Analysis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551.
   PubMed Web of Science ®Google Scholar
• Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol. 2002;167(6):2435–2439.
   PubMed Web of Science ®Google Scholar
• Heijmink SW, van Moerkerk H, Kiemeney LA, Witjes JA, Frauscher F, Barentsz JO. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol. 2006;16(4):927–938. doi:10.1007/s00330-005-0035-y.
   PubMed Web of Science ®Google Scholar
• Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151(6):1571–1574. doi:10.1016/s0022-5347(17)35304-1.
   PubMed Web of Science ®Google Scholar
• Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–1328. doi:10.1056/NEJMoa0810084.
   PubMed Web of Science ®Google Scholar
• Murphy G, Haider M, Ghai S, Sreeharsha B. The expanding role of MRI in prostate cancer. Am J Roentgenol. 2013;201(6):1229–1238. doi:10.2214/AJR.12.10178.
   PubMed Web of Science ®Google Scholar
• Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, et al. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol. 2012;19(10):1215–1224. doi:10.1016/j.acra.2012.05.016.
   PubMed Web of Science ®Google Scholar
• Drost FH, Osses DF, Nieboer D, Steyerberg EW, Bangma CH, Roobol MJ, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019;4:CD012663. doi:10.1002/14651858.CD012663.pub2.
   PubMedGoogle Scholar
• Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-00009.
   PubMed Web of Science ®Google Scholar
• Miyagawa T, Ishikawa S, Kimura T, Suetomi T, Tsutsumi M, Irie T, et al. Real-time virtual sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data. Int J Urol. 2010;17(10):855–860. doi:10.1111/j.1442-2042.2010.02612.x.
   PubMed Web of Science ®Google Scholar
• Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012;188(6):2152–2157. doi:10.1016/j.juro.2012.08.025.
   PubMed Web of Science ®Google Scholar
• Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014;65(4):809–815. doi:10.1016/j.eururo.2013.03.025.
   PubMed Web of Science ®Google Scholar
• Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol. 2015;68(4):713–720. doi:10.1016/j.eururo.2015.06.008.
   PubMed Web of Science ®Google Scholar
• Mendhiratta N, Meng X, Rosenkrantz AB, Wysock JS, Fenstermaker M, Huang R, et al. Prebiopsy MRI and MRI-ultrasound fusion-targeted prostate biopsy in men with previous negative biopsies: impact on repeat biopsy strategies. Urology. 2015;86(6):1192–1199. doi:10.1016/j.urology.2015.07.038.
   PubMedGoogle Scholar
• Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, et al. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int. 2015;115(4):562–70. doi:10.1111/bju.12938.
   PubMed Web of Science ®Google Scholar
• Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, et al. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer. 2016;122(6):884–892. doi:10.1002/cncr.29874.
   PubMed Web of Science ®Google Scholar
• Boesen L, Norgaard N, Logager V, Balslev I, Thomsen HS. A prospective comparison of selective multiparametric magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsies for detecting prostate cancer in men undergoing repeated biopsies. Urol Int. 2017;99(4):384–391. doi:10.1159/000477214.
   PubMed Web of Science ®Google Scholar
• Lian H, Zhuang J, Wang W, Zhang B, Shi J, Li D, et al. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen. BMC Urol. 2017;17(1):52. doi:10.1186/s12894-017-0241-3.
   PubMedGoogle Scholar
• Borkowetz A, Renner T, Platzek I, Toma M, Herout R, Baunacke M, et al. Evaluation of transperineal magnetic resonance imaging/ultrasound-fusion biopsy compared to transrectal systematic biopsy in the prediction of tumour aggressiveness in patients with previously negative biopsy. Urol Int. 2019;102(1):20–26. doi:10.1159/000492495.
   PubMed Web of Science ®Google Scholar
• Maxeiner A, Nest AM, Stephan C, Cash H, Baur ADJ, Fischer T, et al. Additive value of transrectal systematic ventral biopsies in combination with magnet resonance imaging/ultrasound fusion-guided biopsy in patients with 3 or more negative prostate biopsies. Urol Int. 2020;104(3–4):205–213. doi:10.1159/000504266.
   PubMed Web of Science ®Google Scholar
• Preisser F, Theissen L, Wenzel M, Humke C, Bodelle B, Kollermann J, et al. Performance of combined magnetic resonance imaging/ultrasound fusion-guided and systematic biopsy of the prostate in biopsy-naive patients and patients with prior biopsies. Eur Urol Focus. 2021;7(1):39–46. doi:10.1016/j.euf.2019.06.015.
   PubMedGoogle Scholar
• Wang NN, Teslovich NC, Fan RE, Ghanouni P, Leppert JT, Brooks JD, et al. Applying the PRECISION approach in biopsy naive and previously negative prostate biopsy patients. Urol Oncol. 2019;37(8):530 e19–530 e24.
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Kruck S, Kramer U, Gatidis S, Stenzl A, Roethke M, et al. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies. Urol Int. 2015;94(3):319–325. doi:10.1159/000365397.
   PubMed Web of Science ®Google Scholar
• Pepe P, Garufi A, Priolo G, Pennisi M. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Clin Genitourin Cancer. 2015;13(1):e27-e30.
   Web of Science ®Google Scholar
• Boesen L, Noergaard N, Chabanova E, Logager V, Balslev I, Mikines K, et al. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand J Urol. 2015;49(1):25–34. doi:10.3109/21681805.2014.925497.
   PubMed Web of Science ®Google Scholar
• Kulis T, Zekulic T, Alduk AM, Lusic M, Bulimbasic S, Ferencak V, et al. Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam. Croat Med J. 2020;61(1):49–54. doi:10.3325/cmj.2020.61.49.
   PubMed Web of Science ®Google Scholar
• Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, Kummer JA, Vreuls W, et al. Is there still a need for repeated systematic biopsies in patients with previous negative biopsies in the era of magnetic resonance imaging-targeted biopsies of the prostate? Eur Urol Oncol. 2020;3(2):216–223. doi:10.1016/j.euo.2019.06.005.
   PubMed Web of Science ®Google Scholar
• Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol. 2015;68(3):438–450. doi:10.1016/j.eururo.2014.11.037.
   PubMed Web of Science ®Google Scholar
• Pokorny MR, de Rooij M, Duncan E, Schroder FH, Parkinson R, Barentsz JO, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol. 2014;66(1):22–29. doi:10.1016/j.eururo.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, et al. The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol. 2019;75(4):582–590. doi:10.1016/j.eururo.2018.11.040.
   PubMed Web of Science ®Google Scholar
• Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–262. doi:10.1016/j.eururo.2020.09.042.
   PubMed Web of Science ®Google Scholar
• Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, et al. An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–334. doi:10.1016/j.juro.2017.01.103.
   PubMed Web of Science ®Google Scholar
• Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst. 2007;99(18):1395–1400. doi:10.1093/jnci/djm119.
   PubMedGoogle Scholar